ScholarIQanswers from OpenAlex

Grass pollen immunotherapy induces Foxp3-expressing CD4+CD25+ cells in the nasal mucosa

PaperCitations, authors & open-access status

Grass pollen immunotherapy induces Foxp3-expressing CD4+CD25+ cells in the nasal mucosa is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Grass pollen immunotherapy induces Foxp3-expressing CD4+CD25+ cells in the nasal mucosa have?

ScholarIQcitation count

Grass pollen immunotherapy induces Foxp3-expressing CD4+CD25+ cells in the nasal mucosa has 331 citations in the OpenAlex counts ScholarIQ stores.

When was Grass pollen immunotherapy induces Foxp3-expressing CD4+CD25+ cells in the nasal mucosa published?

ScholarIQyear

Grass pollen immunotherapy induces Foxp3-expressing CD4+CD25+ cells in the nasal mucosa has 2008 year in the ScholarIQ index.

What is the open-access status of Grass pollen immunotherapy induces Foxp3-expressing CD4+CD25+ cells in the nasal mucosa?

ScholarIQoa status

Grass pollen immunotherapy induces Foxp3-expressing CD4+CD25+ cells in the nasal mucosa has bronze oa status in the ScholarIQ index.

What is the DOI of Grass pollen immunotherapy induces Foxp3-expressing CD4+CD25+ cells in the nasal mucosa?

ScholarIQdoi

The DOI for Grass pollen immunotherapy induces Foxp3-expressing CD4+CD25+ cells in the nasal mucosa is on the source record.

What is the PMID of Grass pollen immunotherapy induces Foxp3-expressing CD4+CD25+ cells in the nasal mucosa?

ScholarIQpmid

The PMID for Grass pollen immunotherapy induces Foxp3-expressing CD4+CD25+ cells in the nasal mucosa is on the source record.

What is the OpenAlex record for Grass pollen immunotherapy induces Foxp3-expressing CD4+CD25+ cells in the nasal mucosa?

ScholarIQopenalex

The OpenAlex for Grass pollen immunotherapy induces Foxp3-expressing CD4+CD25+ cells in the nasal mucosa is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial